Search Results Search Sort by RelevanceMost Recent Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605. Viewpoint Nov 2001 Commemorative Issue: The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2001;3(11):379-380. doi: 10.1001/virtualmentor.2001.3.11.dykn1-0111. Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Viewpoint Dec 2002 The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):370-371. doi: 10.1001/virtualmentor.2002.4.12.dykn1-0212.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.
Case and Commentary May 2016 Consequences for Patients and Their Loved Ones When Physicians Refuse to Participate in Ethics Consultation Processes David S. Seres, MD, ScM While some physicians try to avoid ethics consultations, their participation can be essential for good patient care. AMA J Ethics. 2016;18(5):493-498. doi: 10.1001/journalofethics.2016.18.5.ecas3-1605.
Viewpoint Nov 2001 Commemorative Issue: The Twelve Days of Christmas Audiey Kao, MD, PhD Virtual Mentor. 2001;3(11):379-380. doi: 10.1001/virtualmentor.2001.3.11.dykn1-0111.
Case and Commentary Feb 2013 Profiling Patients to Identify Prospective Donors Richard E. Thompson, MD If wealth screening and patient care must be mixed, they would be safer and more effective if guided by a policy developed with input from physicians. Virtual Mentor. 2013;15(2):114-118. doi: 10.1001/virtualmentor.2013.15.2.ecas3-1302.